Product Information

GEMCITABINE HCL 1 GRAM VIAL is a generic product labeled by Hospira Inc., priced at $19.9960 per EA under NDC 00409018601. Its NADAC has been published 69 times since Oct 23, 2024.

FDA first approved this application on Jul 25, 2011. Its Orange Book therapeutic-equivalence code is AP.

GEMCITABINE HCL 1 GRAM VIAL

GEMCITABINE
$19.9960per EA

Strength

38 mg/mL

Manufacturer

Hospira Inc.

NDC

00409018601

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS

Effective Date

2/19/2025

Active Ingredients

GEMCITABINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078339

FDA Approved

7/25/2011

TE Code

AP

On Market Since

7/26/2011

Pharmacological Classes

Nucleic Acid Synthesis Inhibitors
Nucleoside Metabolic Inhibitor

Price Statistics

The NADAC for GEMCITABINE HCL 1 GRAM VIAL has been published 69 times since Oct 23, 2024, and over the history we have for it it has declined 5.8%. The table below summarizes its recorded NADAC range and movement.

Current price$19.9960 per EA
All-time high$21.2267 (Dec 11, 2024)
All-time low$19.9960 (Feb 19, 2025)
52-week high$19.9960
52-week low$19.9960
Median price$19.9960
Average price$20.2338
Largest weekly change-3.0% (Feb 19, 2025)
Weeks tracked69
Tracking sinceOct 23, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

0.0%

3Y

N/A

5Y

N/A

All

-5.8%

Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GEMCITABINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of GEMCITABINE HCL 1 GRAM VIAL?

The current National Average Drug Acquisition Cost (NADAC) for GEMCITABINE HCL 1 GRAM VIAL, manufactured by Hospira Inc., is $19.9960 per EA (NDC 00409018601), effective Feb 11, 2026.

How has the price of GEMCITABINE HCL 1 GRAM VIAL changed over time?

Over the history we have for it, the NADAC for GEMCITABINE HCL 1 GRAM VIAL has declined 5.8%. It has been tracked across 69 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for GEMCITABINE HCL 1 GRAM VIAL?

Since Oct 23, 2024, the NADAC for GEMCITABINE HCL 1 GRAM VIAL has ranged from a low of $19.9960 (Feb 19, 2025) to a high of $21.2267 (Dec 11, 2024), with a median of $19.9960 per EA.

Are there cheaper alternatives to GEMCITABINE HCL 1 GRAM VIAL?

No other NADAC-published product currently shares the active ingredient and strength of GEMCITABINE HCL 1 GRAM VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GEMCITABINE HCL 1 GRAM VIAL?

GEMCITABINE HCL 1 GRAM VIAL (NDC 00409018601) is labeled by Hospira Inc., and CMS classifies it as a generic product.